QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

DRUG

QT57Bright Minds Biosciences Inc.
NASDAQ·Healthcare·Biotechnology·Canada
Latest market price
60.66
+1.14+1.92%
OverviewShort InterestFilings
DRUGQT57Bright Minds Biosciences Inc.·NASDAQ
OverviewShort InterestFilings
60.66+1.92%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own10.80%
Shs Outstand9.81M
Perf Week-1.48%
Market Cap465.37MForward P/E-EPS next Y-8.62Insider Trans-1.11%Shs Float-Perf Month-18.62%
Enterprise Value247.09MPEG0.27EPS next Q-0.91Inst Own-Short Float-Perf Quarter-16.08%
Income-15729658.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-35.46%
Sales-P/B2.64EPS next Y-88.26%ROA-8.83%Short Interest-Perf YTD-22.27%
Book/sh6.01P/C-EPS next 5Y-ROE-20.73%52W High123.75 -50.98%Perf Year119.07%
Cash/sh6.12P/FCF-EPS past 3/5Y-ROIC-10.20%52W Low23.18 161.69%Perf 3Y-
Dividend Est.-EV/EBITDA-11.15Sales past 3/5Y-Gross Margin0.00%Volatility4.40% 4.76%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-410.61%Oper. Margin0.00%ATR (14)4.93Perf 10Y-
Dividend Ex-Date-Quick Ratio81.48Sales Y/Y TTM-Profit Margin0.00%RSI (14)30.14Recom2.00
Dividend Gr. 3/5Y-Current Ratio81.48EPS Q/Q-SMA20-16.31%Beta1.96Target Price146.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA50-24.68%Rel Volume0.81Prev Close59.52
Employees26LT Debt/Eq-EarningsAug 13SMA200-16.70%Avg Volume296.53KPrice60.66
IPO DateMar 22, 2021Option/ShortYes / YesEPS/Sales Surpr.31.62% -Net Debt/EBITDA9.85Volume238,787Change1.92%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-02-26ReiteratedH.C. Wainwright$85 → $145
May-20-26ReiteratedPiper SandlerOverweight$220
Feb-13-26ReiteratedRobert W. Baird$142 → $126
Jan-07-26ReiteratedRobert W. Baird$82 → $142
Jan-07-26ReiteratedBTIGBuy$147
Jan-06-26ReiteratedBTIGBuy$147
May-07-25InitiatedChardanBuy$80
Jan-10-25InitiatedH.CBuy$85
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
9/30/2025
FY 2024
9/30/2024
FY 2023
9/30/2023
FY 2022
9/30/2022
FY 2021
9/30/2021
FY 2020
9/30/2020
FY 2019
9/30/2019
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other212
Research and Development814
Other Operating Expense00-1
Operating Income-10-2-5
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-100
Net Income Before Taxes-9-2-5
Income Taxes
000
Consolidated Net Income-9-2-5
Net Income From Continuing Operations-9-2-5
Net Income-9-2-5
EPS (Recurring)-1.27-0.48-1.47
EPS (Basic, Before Extraordinaries)-1.27-0.48-1.47
EPS (Diluted)-1.27-0.48-1.47
EBITDA-9-2-5
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding744
Market Capitalization425——
Operating Lease Expense
———
Insider Trading Volume
$65.14$55.82$46.51$37.20$27.88● Close Price0.00M2.45M4.89M7.34M9.79MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cormorant Asset Management, LPother: Former 10% OwnerApr 28 '26Sale89.50109,3319,785,125950,000Apr 30 12:00 AM
Cormorant Asset Management, LP10% OwnerNov 04 '24Buy21.70184,3313,999,9831,059,331Nov 06 12:00 AM
Cormorant Asset Management, LP10% OwnerOct 16 '24Buy23.4650,0001,172,814875,000Oct 17 12:00 AM
Cormorant Asset Management, LP10% OwnerOct 15 '24Buy5.53372,5912,061,573825,000Oct 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR